Corbus Pharmaceuticals Holdings Inc (CRBP)

7.94 -0.09  -1.12% NASDAQ Jul 8, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
08/07/2020 08:30 EDT Misc Corbus Pharmaceuticals Holdings Inc Second Quarter Earnings Conference Call in 2020
08/07/2020 Earnings Corbus Pharmaceuticals Holdings Inc Second Quarter Earnings in 2020 Release
05/20/2020 09:00 EDT Misc Corbus Pharmaceuticals Holdings Inc Annual General Meeting for 2019
05/11/2020 08:30 EDT Misc Corbus Pharmaceuticals Holdings Inc First Quarter Earnings Conference Call for 2020
05/11/2020 Earnings Corbus Pharmaceuticals Holdings Inc First Quarter Earnings Result for 2020
03/16/2020 Misc Corbus Pharmaceuticals Holdings Inc Annual Report for 2019
03/12/2020 08:30 EDT Misc Corbus Pharmaceuticals Holdings Inc Fourth Quarter Earnings Conference Call for 2019
03/12/2020 Earnings Corbus Pharmaceuticals Holdings Inc Fourth Quarter Earnings in 2019 Release
11/07/2019 08:30 EST Misc Corbus Pharmaceuticals Holdings Inc Third Quarter Earnings Conference Call for 2019
11/07/2019 Earnings Corbus Pharmaceuticals Holdings Inc Third Quarter Earnings in 2019 Release
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.corbuspharma.com
  • Investor Relations URL: N/A
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Aug. 07, 2020
  • Last Earnings Release: May. 11, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Corbus Pharmaceuticals Holdings Inc is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus.

Top Fund Holders

Symbol Name Weighting
MJ ETFMG Alternative Harvest ETF 5.34%
MJ ETFMG Alternative Harvest ETF 5.34%
POTX Global X Cannabis ETF 5.30%
POTX Global X Cannabis ETF 5.30%
AMRHX American Growth Fund Series Two F 4.70%
FPQPUX FT Top Picks May 2020 RE 3.62%
YOLO AdvisorShares Pure Cannabis ETF 3.27%
YOLO AdvisorShares Pure Cannabis ETF 3.27%
TOKE Cambria Cannabis ETF 2.87%
CANNX Cannabis Growth Investor 2.27%
HMMJ.TO Horizons Marijuana Life Sciences ETF 1.59%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.